Now more than ever, the scientific community is looking to see how we can support each other. Thermo Fisher Scientific is here to help; we are now offering free use of Thermo Fisher™ Platform for Science™ software to academic laboratories performing SARS-CoV-2 research for up to a year. We have designed a prepackaged solution made up of capabilities to specifically support SARS-CoV-2 research studies.
What’s included in the solution?
The solution comprises both Laboratory Information Management System (LIMS) and Electronic Laboratory Notebook (ELN) capabilities by utilizing Thermo Scientific™ Core LIMS™ and Core ELN™ software. Prepackaged configurations for sample registration, inventory management, and instrument management are included in the solution. To specifically support your genomics research data, we have configured experiments for qPCR, Next Generation Sequencing, and Sanger/Capillary Electrophoresis workflows.
The deployment of this solution will occur in the Amazon Web Services cloud and will be managed by Thermo Fisher. The team at Thermo Fisher is ready to support your cloud deployment and has continuous monitoring in place to help ensure that your data is safe and secure. In addition, utilizing a cloud infrastructure to support your SARS-CoV-2 research makes your data accessible 24x7x365 for collaboration.
How will this solution streamline our research initiatives?
The SARS-CoV-2 solution for academic laboratories helps to ensure that all your critical research data is captured and stored. It also provides:
- Complete end-to-end tracking of samples
- Visibility into assays and experiments
- Central storage of critical assay data
- Contemporaneous recording of assay and experiment observation
Holistic data management is critical to producing high-quality data, and we want to provide a free mechanism to facilitate this. To learn whether this solution is a fit for your academic laboratory’s SARS-CoV-2 research initiatives, contact us at 1 800 395 5467x 2103501. Thermo Fisher is here to help you fight this global pandemic.